| Mucotex 250 mg/5 ml syrup PA23153/001/001 |
Carbocisteine |
Amdeepcha (Malta) Ltd |
Not marketed |
| Mulpleo EU/1/18/1348/001 |
LUSUTROMBOPAG |
Shionogi B.V. |
— |
| MULTAQ 400 mg film-coated tablets EU/1/09/591/1-4 |
Dronedarone hydrochloride |
Sanofi Winthrop Industrie |
— |
| multiBic 2 mmol/l potassium solution for haemodialysis/haemofiltration PA1350/009/002 |
Sodium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Glucose monohydrate, Sodium hydrogen carbonate |
Fresenius Medical Care Deutschland GmbH |
Marketed |
| multiBic 4 mmol/l potassium solution for haemodialysis/haemofiltration PA1350/009/003 |
Sodium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Glucose monohydrate, Sodium hydrogen carbonate |
Fresenius Medical Care Deutschland GmbH |
Marketed |
| multiBic potassium-free solution for haemodialysis/haemofiltration PA1350/009/001 |
Sodium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Glucose monohydrate, Sodium hydrogen carbonate |
Fresenius Medical Care Deutschland GmbH |
Marketed |
| MultiHance 529 mg/ml solution for injection in pre-filled syringe PA1826/001/002 |
Gadobenate dimeglumine |
Bracco Imaging spa |
Marketed |
| MultiHance, 0.5M solution for injection PA1826/001/001 |
Gadobenate dimeglumine |
Bracco Imaging spa |
Marketed |
| Murexal 10 mg/mL solution for injection in pre-filled syringe PA1968/010/001 |
Suxamethonium chloride |
Laboratoire Aguettant |
Marketed |
| Murine irritation & redness relief, 0.012% w/v, eye drops solution PA22637/008/001 |
Naphazoline hydrochloride |
Elara Pharmaservices Europe Limited |
Marketed |
| MVASI 25 mg/mL Concentrate for solution for infusion EU/1/17/1246/001-002 |
Bevacizumab |
Amgen Technology (Ireland) Unlimited Company |
— |
| Myalepta 11.3 mg powder for solution for injection EU/1/18/1276/001-002 |
Metreleptin |
Chiesi Farmaceutici S.p.A. |
— |
| Mybufen 200 mg Film-coated Tablets PA1436/039/001 |
Ibuprofen |
Bluefish Pharmaceuticals AB |
Marketed |
| Mybufen Max 400 mg Film-coated Tablets PA1436/039/002 |
Ibuprofen |
Bluefish Pharmaceuticals AB |
Marketed |
| Mybufen Max Rapid 400 mg soft capsules PA1436/046/001 |
Ibuprofen |
Bluefish Pharmaceuticals AB |
Not marketed |
| Mycamine 100 mg powder for solution for infusion EU/1/08/448/002 |
Micafungin sodium |
Sandoz Pharmaceuticals d.d. |
— |
| Mycamine 50 mg powder for concentrate for solution for infusion EU/1/08/448/001 |
Micafungin sodium |
Sandoz Pharmaceuticals d.d. |
— |
| Myclausen 500 mg film-coated tablets EU/1/10/647/001-002 |
Mycophenolate mofetil |
Herbert J. Passauer GmbH & Co. KG |
— |
| Myclausen 500 mg film-coated tablets EU/1/10/647/003-004 |
Mycophenolate mofetil |
Herbert J. Passauer GmbH & Co. KG |
— |
| Mycobutin 150mg Hard Capsules PA0822/109/001 |
Rifabutin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Mycolat 250 mg hard capsules PA0711/129/001 |
Mycophenolate mofetil |
Rowex Limited, |
Marketed |
| Mycolat 500 mg Film-coated tablets PA0711/129/002 |
Mycophenolate mofetil |
Rowex Limited, |
Marketed |
| Mycophenolate Mofetil 500 mg film-coated Tablets PA2315/192/001 |
Mycophenolate mofetil |
Accord Healthcare Ireland Ltd. |
Marketed |
| Mycophenolate Mofetil Accord 250 mg capsules PA2315/064/001 |
Mycophenolate mofetil |
Accord Healthcare Ireland Ltd. |
Marketed |
| Mycophenolate mofetil Teva 250 mg Capsule, hard EU/1/07/439/1-2 |
Mycophenolate mofetil |
Teva B.V. |
— |
| Mycophenolate mofetil Teva 500 mg Capsule, hard EU/1/07/439/3-4 |
Mycophenolate mofetil |
Teva Pharma B.V. |
— |
| Mycostatin 100,000 units/ml Oral Suspension (Ready Mixed) PA1677/007/007 |
Nystatin |
Substipharm |
Marketed |
| Myfenax 250 mg Capsule, hard EU/1/07/438/1-2 |
Mycophenolate mofetil |
Teva B.V. |
— |
| Myfenax 500 mg Film-coated tablet EU/1/07/438/3-4 |
Mycophenolate mofetil |
Teva B.V. |
— |
| Myfortic 180 mg gastro-resistant tablets PA0896/023/001 |
Mycophenolic acid |
Novartis Ireland Limited |
Marketed |
| Myfortic 360 mg gastro-resistant tablets PA0896/023/002 |
Mycophenolic acid |
Novartis Ireland Limited |
Marketed |
| Myfortic 360 mg gastro-resistant tablets PPA0465/505/001 |
Mycophenolate sodium |
PCO Manufacturing Ltd. |
— |
| Myfortic 360 mg gastro-resistant tablets PPA1463/233/001 |
Mycophenolic acid |
IMED Healthcare Ltd. |
— |
| Mykronor 5 micrograms/ml, solution for injection/infusion PA1968/013/001 |
Noradrenaline tartrate |
Laboratoire Aguettant |
Not marketed |
| Mylatabi 25 mg film-coated tablets PA25239/004/001 |
Eltrombopag olamine |
Tillomed Malta Limited |
Not marketed |
| Mylatabi 50 mg film-coated tablets PA25239/004/002 |
Eltrombopag olamine |
Tillomed Malta Limited |
Not marketed |
| Mylatabi 75 mg film-coated tablets PA25239/004/003 |
Eltrombopag olamine |
Tillomed Malta Limited |
Not marketed |
| Myleran 2 mg film-coated tablets PA1691/008/001 |
Busulfan |
Aspen Pharma Trading Limited |
Not marketed |
| MYLOTARG 5 mg powder for concentrate for solution for infusion EU/1/18/1277/001 |
Gemtuzumab ozogamicin |
Pfizer Europe MA EEIG |
— |
| MYNZEPLI 40 mg/mL solution for injection in a vial EU/1/25/1964/001 |
Aflibercept |
Advanz Pharma Limited |
— |
| MYNZEPLI 40 mg/mL solution for injection in pre-filled syringe EU/1/25/1964/002 |
Aflibercept |
Advanz Pharma Limited |
— |
| Myocet liposomal 50 mg powder, dispersion and solvent for concentrate for dispersion for infusion EU/1/00/141/001 |
DOXORUBICIN HYDROCHLORIDE |
CHEPLAPHARM Arzneimittel GmbH |
— |
| MYOVIEW 230 micrograms kit for radiopharmaceutical preparation PA0735/012/001 |
Tetrofosmin |
GE Healthcare AS |
Not marketed |
| Myozyme 50 mg powder for concentrate for solution for infusion EU/1/06/333/1-3 |
Alglucosidase alfa |
Sanofi B.V. |
— |
| Myrelez 120 mg solution for injection in pre-filled syringe PA1142/039/003 |
Lanreotide |
Amdipharm Limited |
— |
| Myrelez 60 mg solution for injection in pre-filled syringe PA1142/039/001 |
Lanreotide |
Amdipharm Limited |
— |
| Myrelez 90 mg solution for injection in pre-filled syringe PA1142/039/002 |
Lanreotide |
Amdipharm Limited |
— |
| Mysildecard 20 mg film-coated tablets EU/1/16/1134/001-003 |
Sildenafil citrate |
Viatris Limited |
— |
| Mysimba 8 mg/90 mg prolonged-release tablets EU/1/14/988/001-002 |
Naltrexone hydrochloride, Bupropion hydrochloride |
Orexigen Therapeutics Ireland Limited |
— |
| Mysoline 250mg Tablets PA1777/001/001 |
Primidone |
Laboratoires SERB |
Marketed |